Masimo's Multigas Monitoring Module Gets 510(k), CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 4:55PM CST
Masimo Corporation's (MASI) ISA OR+ multigas monitoring is a Masimo Open Connect (MOC-9) Module for the Root patient monitoring and connectivity platform.
MASI: 26.60 (+0.04), GMED: 24.37 (+0.44), COV: 103.35 (+0.57), EW: 130.75 (+1.17)
North America Spinal Surgery Market - Industry Analysis And Market Forecast 2014-2020
M2 - Tue Dec 09, 8:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/w58zvn/north_america) has announced the addition of the "North America Spinal Surgery Market - Industry Analysis And Market Forecast 2014-2020" report to their offering. The North American market for Spinal Surgery is estimated to be valued as $7.76 billion for the year 2014 and is expected to reach $11.28 billion by the end of 2020. The CAGR during this period of forecast is 6.43%. Spinal surgical device market is a very significant and money-spinning sub section of orthopedic industry. Spine surgery is traditionally done as "open surgery," wherein a long incision allows the surgeon to access the spine anatomy. In the recent years, a minimally invasive surgical device technique has received increasing attention as it does not involve a long incision and hence causes minimal damage to the muscles around the spine. This results in lesser post-operative pain and faster recovery. Spinal surgeries can be classified as: - ALIF (Anterior Lumbar Interbody Fusion): for removal of a complete intervertebral disc. - Anterior Cervical Discectomy: to remove selected discs. - Bone Grafting: to place bone into an area of the spine in order to get solid bone healing (spinal fusion). - Discectomy: to remove a part or all of an intervertebral disc from the spine. - Spinal Decompression - Spinal Fusion - Spinal Instrumentation - Spinal Osteotomy - Thoracoscopic Release - TLIF The major players in this market are Globus Medical, Zimmer Holdings, Medtronic, Paradigm Spine, Stryker Corporation and Aplhatec Holdings. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. North American Spinal Surgery Market Segmentation 5. Competitive Landscape 6. Company Profiles For more information visit http://www.researchandmarkets.com/research/w5...th_america
ZMH: 114.11 (+0.64), MDT: 74.08 (+0.31), GMED: 24.37 (+0.44), SYK: 96.00 (-0.61)
Globus Medical: Best Positioned Play In The Spine Recovery Market
Value Wagon - at Seeking Alpha - Thu Nov 20, 8:26AM CST
GMED: 24.37 (+0.44)
Exactech's Equinoxe Shoulder System: 10 Years of Success - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 4:55PM CST
Developer of orthopedic implant devices Exactech Inc. (EXAC) recently announced the 10th year anniversary of its Equinoxe Shoulder System, a product line in its shoulder business.
ZMH: 114.11 (+0.64), GMED: 24.37 (+0.44), EXAC: 22.68 (+0.24), SYK: 96.00 (-0.61)
Exactech's (EXAC) Octane Elevate to Advance Spine Surgery - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:15PM CST
Developer of orthopedic implant devices, Exactech Inc. (EXAC), recently announced the launch of Octane Elevate, a self-distracting lumber fusion device made of Poly Ether Ether Ketone (PEEK), a colorless organic thermoplastic polymer.
ZMH: 114.11 (+0.64), GMED: 24.37 (+0.44), EXAC: 22.68 (+0.24), SYK: 96.00 (-0.61)
Globus Medical to Redefine Spinal Fusion with ALTERA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:07PM CST
Manufacturer of musculoskeletal implants, Globus Medical Inc. (GMED), recently announced the launch of ALTERA, which is claimed to be the first minimally intrusive expandable spacer.
ZMH: 114.11 (+0.64), GMED: 24.37 (+0.44), EXAC: 22.68 (+0.24), SYK: 96.00 (-0.61)
Abiomed (ABMD) Hits 52-Week High on Strong Q2 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 10:10AM CST
Shares of Abiomed, Inc. (ABMD) have been on the rise since it reported impressive second-quarter fiscal 2015 (ended Sep 30, 2014) results on Oct 30.
ABMD: 38.46 (+0.13), FLDM: 32.31 (+0.30), GMED: 24.37 (+0.44), ANGO: 19.19 (+0.33)
Global Orthopedic Implant Physician Preference Survey 2015 - Executive Summary
M2 - Wed Nov 12, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkgmtc/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015 (Executive Summary)" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Key Topics Covered: - Survey Background - Survey Respondent Profile - Knee Repair Products - Foot Digit Repair Products - Hip Repair Products - Hand Digit Repair Products - Spinal Surgery Products - Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/wk...orthopedic
SNN: 38.18 (+0.14), MDT: 74.08 (+0.31), GMED: 24.37 (+0.44)
Global Orthopedic Implant Physician Preference Survey 2015
M2 - Wed Nov 12, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/9rfcq6/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Survey includes: - Patient Volumes - Procedures Performed - Clinical Setting - Product prerference by manufacturer - Factors influencing produt change - Preferences by region, country and clinical setting Key Topics Covered: 1. Executive Summary 2. Research Methodology And Survey Coverage 3. Survey Respondent Profile 4. Osteoarthritis Treatment Preferences 5. Product Preference Overview 6. Knee Repair Products 7. Hip Repair Products 8. Hand Digit Repair Products 9. Foot Digit Repair Products 10. Cervical Interbody Products 11. Thoracolumbar Interbody Products 12. Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/9r...orthopedic
SNN: 38.18 (+0.14), MDT: 74.08 (+0.31), GMED: 24.37 (+0.44)
Globus Medical Announces ALTERA(TM) Minimally Invasive Articulating Expandable Spacer
Business Wire - Tue Nov 11, 11:38PM CST
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, and the worldwide leader in expandable interbody technology, today announced the launch of ALTERA(TM), the first new minimally invasive fully articulating expandable spacer for spinal fusion. Designed for restoring lordosis and maintaining sagittal balance while reducing the challenges of insertion, the spacer is inserted at a minimized height, articulated into an anterior position, and then expanded vertically to optimize fit. The company is showcasing ALTERA(TM) as well as several recently launched products at the North American Spine Society (NASS) Annual Meeting, being held in San Francisco this week, Booth #1119.
GMED: 24.37 (+0.44), ALTR: 37.97 (+0.23)
NYSE stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
RATE: 12.63 (-0.01), RAX: 48.24 (+0.45), PVG.TO: 5.91 (+0.20), PVG: 5.07 (+0.14), THO.TO: 15.46 (+0.63), ZTS: 43.84 (+0.87), W: 20.44 (-0.35), GLP: 34.90 (-0.19), GMED: 24.37 (+0.44), EGO: 5.97 (+0.18), DWRE: 58.40 (-0.06), PLOW: 21.71 (-0.20), ELD.TO: 6.97 (+0.25), DF: 18.96 (-0.01), TAHO: 13.31 (+0.56)
Technical Coverage on Health Care Equipment Stocks - Boston Scientific, Zeltiq Aesthetics, Globus Medical, Volcano, and Stryker
PR Newswire - Thu Nov 06, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ), Globus Medical Inc. (NYSE: GMED), Volcano Corporation (NASDAQ: VOLC), and Stryker Corporation (NYSE: SYK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Wednesday, November 5, 2014, the NASDAQ Composite ended at 4,620.72, down 0.06%, the Dow Jones Industrial Average advanced 0.58%, to finish the day at 17,484.53, and the S&P 500 closed at 2,023.57, up 0.57%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.22, down 0.19%, while the index has advanced 10.98% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.13 (+0.07), ZLTQ: 28.73 (-0.19), GMED: 24.37 (+0.44), VOLC: 17.95 (+0.02), SYK: 96.00 (-0.61)
Globus Medical (GMED) Upgraded From Hold to Buy
at The Street - Wed Nov 05, 8:25AM CST
Globus Medical (GMED) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
GMED: 24.37 (+0.44)
Globus Medical ups earnings 14% in Q3
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 3:41PM CDT
GMED: 24.37 (+0.44)
Globus' (GMED) CEO David Paul on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 9:51PM CDT
GMED: 24.37 (+0.44)
Globus Medical beats 3Q profit forecasts
Automated Insights - Thu Oct 30, 6:37PM CDT
AUDUBON, Pa. (AP) _ Globus Medical Inc. (GMED) on Thursday reported earnings of $23.1 million in its third quarter.
GMED: 24.37 (+0.44)
Globus Medical Reports 2014 Third Quarter Results
Business Wire - Thu Oct 30, 3:30PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2014.
GMED: 24.37 (+0.44)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:35PM CDT
ELLI: 41.40 (+0.81), AIV: 37.80 (-0.33), EPAY: 25.23 (-0.04), CPSI: 61.11 (-0.09), LNKD: 231.83 (+0.34), ADNC: 4.15 (+0.01), CODE: 34.55 (+0.64), HME: 66.47 (-0.43), ESIO: 7.76 (+0.13), HIL: 3.69 (-0.05), DGI: 30.85 (+0.27), AHT: 10.87 (-0.04), COLM: 44.76 (-0.62), AHS: 19.89 (+0.14), CSLT: 12.14 (+0.30), FRT: 136.26 (-0.13), DGII: 9.15 (+0.15), ADUS: 23.80 (-0.19), ESS: 210.72 (-1.86), EXPE: 89.01 (+0.09), IMPV: 51.87 (+1.18), CCI: 79.05 (-0.13), CPT: 75.44 (-0.56), GB: 49.34 (-0.36), AEGR: 21.59 (-0.27), ATEN: 4.29 (+0.01), ELGX: 15.35 (-0.06), AFFX: 9.80 (+0.05), CHE: 106.16 (+0.13), BCOV: 7.88 (-0.05), DCT: 35.96 (+0.21), ELX: 5.75 (+0.03), GNMK: 13.67 (+0.06), AXTI: 2.65 (-0.09), INT: 47.79 (-0.05), EGN: 64.33 (-0.02), EGO: 5.97 (+0.18), GMED: 24.37 (+0.44), GDOT: 20.42 (+0.25), KEG: 1.73 (+0.01), ISBC: 11.14 (+0.04), GRPN: 7.89 (-0.14), ALJ: 12.54 (+0.04), CTRL: 14.57 (-0.04), GPRO: 66.41 (+4.87), EMN: 76.80 (+0.04), IMMR: 9.45 (+0.47), CUBE: 22.59 (+0.08), BYI: 83.27 (unch), ATRC: 18.76 (+0.13), BYD: 12.28 (+0.14), FLDM: 32.31 (+0.30), BEAT: 10.15 (+0.09), FLR: 60.30 (-0.26), FLT: 149.17 (-0.93), EHTH: 27.13 (+0.97)
Globus Medical Announces Acquisition of Transplant Technologies of Texas
Business Wire - Thu Oct 23, 3:25PM CDT
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). Based in San Antonio, TTOT is a provider of human tissue products including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.
GMED: 24.37 (+0.44)